TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Biofourmis Stock

Biofourmis Stock

biofourmis.comHealthcare / Digital HealthFounded: 2018

Biofourmis is a health analytics platform designed to analyze physiology data from clinical-grade wearables. The company's platform uses artificial intelligence to integrate and analyze continuous physiology data from clinical-grade wearables to detect personalized patterns and predict clinical exacerbation in advance of a critical event, enabling medical professionals to intervene days before a critical event and providing better outcomes for patients. Biofourmis utilizes machine learning, integrated biometric data and FDA-cleared analytics to streamline patient care.

Buy or sell Biofourmis stockLearn more about Biofourmis IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Biofourmis, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Biofourmis’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Biofourmis.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Biofourmis investors also invested in these private companies

Sequoia Capital India
Intel Capital
Openspace Ventures
EDBI
MassMutual
CVS Health Ventures
2050 Capital

Team

Management Team

Kuldeep Singh Rajput
Founder & Chief Executive Officer
Mark Niu
Co-founder & Chief Privacy Officer
Maulik Majmudar, MD
Co-founder & Chief Medical Officer
Milan Shah
Chief Technology Officer
Jaydev Thakkar
Chief Operating Officer
Sheeza Khawar Hussain
Chief Commercial Officer
Matt Borowiecki
Chief Financial Officer
Kirsten Carlson
Chief Marketing Officer

Frequently Asked Questions About Biofourmis’ Stock

plusminus
Can you buy Biofourmis’ stock?
Biofourmis is not publicly traded on NYSE or NASDAQ in the U.S. To buy Biofourmis’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Biofourmis’ stock?
Yes, you can sell stock of a private company like Biofourmis. Forge can help you sell your Biofourmis stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Biofourmis’ stock price?
Biofourmis is a privately held company and therefore does not have a public stock price. However, you may access Biofourmis’ private market stock price with Forge Data.
plusminus
What is Biofourmis’ stock ticker symbol?
Biofourmis does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Biofourmis in the Digital Health sector

OURA

Sector
Healthcare / Digital Health
 
 

Brightline

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$705.25MM

ZocDoc

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$2.62B

Hinge Health

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$6.2B

Ro

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$7.19B

Calm

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$404.67MM

Maven

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$1.35B

Included Health

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$1.13B

PathAI

Sector
Healthcare / Digital Health
Last Round Est. Valuation
$1.11B

News Highlights

Boston Business Journal 09/01/2023
Biofourmis CEO steps down one month after layoffs
The article discusses the recent decision by Alphabet Inc. to spin off its self-driving car unit, Waymo, into a separate entity. The move aims to increase transparency and accountability, and may potentially attract external investment. Waymo's development progress and future strategy are also highlighted.
Fierce Healthcare 09/01/2023
Chutes & Ladders‚Amazon One Medical, Biofourmis among high-profile CEO departures
The CEOs of Amazon One Medical and Biofourmis have announced their departures. COO Trent Green will succeed Amir Dan Rubin at One Medical, following Amazon's acquisition of the primary care provider for $3.9 billion in 2022. Meanwhile, Biofourmis is searching for a new CEO after founder Kuldeep Singh Rajput stepped down. The company also added Ben Wanamaker, former VP of enterprise strategy at Humana, to its board of directors.

Trending Companies

Frequently Asked Questions

Updated on: Apr 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.